Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03495388 · ClinicalTrials.gov registry record

PG and PK of Oxycodone to Personalize Post-op Pain Management Following Surgery in Children

A clinical trial of Postoperative Pain and Opioid Dependence, sponsored by Senthil Sadhasivam.

Completed
Registry status
129
Enrollment target
2
Study locations

NCT03495388: Completed study of Postoperative Pain and Opioid Dependence, sponsored by Senthil Sadhasivam.

NCT03495388 is a study of Postoperative Pain and Opioid Dependence that has completed, run by Senthil Sadhasivam. The registered enrollment target is 129 participants, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (44% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03495388, a study of Postoperative Pain and Opioid Dependence, has completed, sponsored by Senthil Sadhasivam.

COMPLETED
Registry status
129 participants
Enrollment target
2
Study locations

Study Summary

Each year, in the U.S. alone, \>6 million children undergo painful surgery; up to 50% of them experience significant and serious side effects with opioids and inadequate pain relief. Though 60% of this inter-individual variability in responses results from genetic variations, there is an almost complete lack of understanding of how specific genetic variability affects pain and of the adverse effects of opioids, especially in children. In this project the investigators will focus on oxycodone, a standard and preferred post-surgical oral analgesic in children The purpose of this research is to study serious immediate and long-term clinical problems from both surgical pain and oxycodone use in children and adolescents to improve the safety and effectiveness of surgical pain relief. The long-term goals are to improve the safety and effectiveness of surgical pain relief with opioids (a class of drugs/pain relievers) and to minimize the societal burden of disabling Chronic Persistent Surgical Pain (CPSP, which is pain that persists even after the expected healing time from surgery) and Opioid Dependence (OD) by preoperative risk predictions and personalized care with the right dose of the right pain medication for each child. The overall objective is to determine the impact of risk factors on oxycodone's immediate and long-term negative postoperative outcomes and to personalize dosing in children undergoing outpatient and major inpatient surgery.

Primary Outcome

The investigators will look at specific CYP2D6, ABCB1, FAAH, OPRM1, and COMT variants to find correlations with children who experience RD, and PONV in the immediate post-surgical period (4 days) in the hospital and at home.

Interventions

  • DRUG Oxycodone

Study Locations (2)

Indiana

  • Riley Hospital for Children - Indianapolis

Pennsylvania

  • UPMC Children's Hospital - Pittsburgh

Trial Details

FieldValue
Enrollment Target 129 participants
Start Date 2018-04-01
Est. Completion 2022-06-15
Senthil Sadhasivam

7 total trials

What the finished NCT03495388 record still lists

NCT03495388 is an observational study that tracks outcomes without assigning an intervention. The registered 129 participants enrollment target is mid-sized for trials with a published cap, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (44% lower).

The record links to 2 conditions, with Postoperative Pain appearing as the primary indexed condition, and to 1 intervention - of which Oxycodone is the first listed.

NCT03495388 reports a single indexed study location in Indiana, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03495388 about?

NCT03495388 is a clinical study titled "PG and PK of Oxycodone to Personalize Post-op Pain Management Following Surgery in Children". Each year, in the U.S. alone, \>6 million children undergo painful surgery; up to 50% of them experience significant and serious side effects with opioids and inadequate pain relief. Though 60% of this inter-individual variability in responses results from genetic variations, there is an almost comp...

What is the current status of trial NCT03495388?

This trial is currently completed. The enrollment target is 129 participants. The study started on 2018-04-01. Estimated completion is 2022-06-15.

What conditions does trial NCT03495388 study?

This clinical trial studies the following conditions: Postoperative Pain, Opioid Dependence.

What interventions are being tested in trial NCT03495388?

The interventions under investigation include: Oxycodone (DRUG).

Who is sponsoring clinical trial NCT03495388?

This trial is sponsored by Senthil Sadhasivam, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03495388 being conducted?

This trial has 2 study locations across Indiana, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postoperative Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03495388's enrollment target sits among peer trials

129 40th of 120 higher than 81 of 120 other Postoperative Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Postoperative Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03619850 · 129 participants · Phase 3

    A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)

  • NCT05704361 · 129 participants · Phase 1

    A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis

  • NCT05919849 · 129 participants · Phase 1

    Supporting Parents in Affirming Their Children's Experiences of Stigma

  • NCT06313749 · 129 participants · NA

    Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03495388, the US trial registry maintained by the National Library of Medicine. NCT03495388 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.